참고문헌
- WHO (World Health Organization). 2020. Coronavirus Disease (COVID-19) Pandemic; 2020 Jun 1 [cited 2020 July 1]. Available from: URL: http://www.who.int/emergencies/diseases/novelcoronavirus-2019.
- Kim DS , Park SJ, Song MD , Chu HM, Kim KH, Choi GH et al. Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis. Integrative Medicine Research, 2020;9(3):1-5. DOI : 10.1016/j.imr.2020.100492 (Korean)
- Angelo C, Roberto B, Francesco L. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5. DOI : 10.1001/jama.2020.12603
- Sandra LL, Talia WO, Carol P, Rosalinda S, Paulina A R, Angelica C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv [online] 2021 [Posted January 30]. DOI : https://doi.org/10.1101/2021.01.27.21250617
- Ani N, Kartik S, Aakriti G, Mahesh V. M, Claire McG, Jacob S.S, et al. Post-acute COVID-19 syndrome. Nature medicine. 2021;27:601-615. https://doi.org/10.1038/s41591-021-01283-z
- Yim YY, Nan SH, Yeo YG, Wang CJ. Analysis on the Therapy of COVID-19 in Guangdong Province Based on the Pattern Differentiation System of Integrated Weifen, Qifen, Yingfen and Xuefen and Visceral Organs. World Science and Technology-Modernization of Traditional Chinese Medicine. 2020;23(2):1-516. DOI :10.11842/wst.20200312009
- Lee KE, Jeong SH, Jeong MJ, Choi YM, Song MD, Jang IS, Review on Herbal Medicine Treatment for Late Complications of COVID-19 Patients. J. Int. Korean Med. 2021;42(1):53-66. DOI :http:/dx.doi.org/10.246/jikm.2021.42.1.53 (Korean)
- Lee BJ, Lee JA, Kim KI, Choi JY, Jung HJ. A consensus guideline of herbal medicine for coronavirus disease 2019. Integrative Medicine Research. 2020;9(3):1-4. DOI : 10.1016/j.imr.2020.100470 (Korean)
- Huang CL, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. DOI : 10.1016/S0140-6736(20)30183-5
- He Ll, Gong PY, Feng Y, Zou W, Wang EL, Gu J. Analysis on application of Chinese materia medica in treatment of COVID-19 by suppressing cytokine storm. Chinese Traditional and Herbal Drugs. 2020;51(6):1375-1385. DOI :10.7501/j.issn.0253-2670.2020.06.002
- Kim TY, Jeon SG, Jang YH, Gotina L, Won JH, Ju YH, et al. Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion. Experimental & Molecular Medicine. 2021;53(5):956-972. DOI : http://dx.doi.org/10.1038/s12276-021-00624-9
- Huang J, Tao G, Liu J, Cai J, Hang Z, Chen JX. Curent Prevention of COVID-19: Natural Products and Herbal Medicine. Frontiers in Pharmacology. 2020;11:58508. DOI : 10.389/fphar.2020.58508.
- Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathul la AS, Kaur P. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics. 2020:1-14. DOI : 10.1080/0739102.2020.1790425
- Kwon SW, Lee WH, Jin C, Jang IS, Jung WS, Moon SK, et al. Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review. Integrative medicine research. 2020;9(3):1-7. DOI : 10.1016/j.imr.2020.100480
- Kwon SW, Chung HB, Kang YG, Jang IS, Choi JY, Jung IC, et al. The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research. Integrative medicine research. 2020;9(3):1-6. DOI : 10.1016/j.imr.2020.100478
- Kim HS, Kim IH. A Study on 「Dongyi Suse Bowon」 Taeumin Onbyung (Epidemic febrile disease) compared with Chinese Febrile Medicine. J Sansang Constitut Med. 2003;15(3):33-61. (Koean)
- Sin SW, Lee JW, Hwang MW, Lee JH, Koh BH, Lee EJ. Modification Principle of Taeeumjowi-tang in Sasang Medicine. J Sansang Constitut Med. 2016;28(3):215-224. DOI : https://doi.org/10.7730/JSCM.2016.28.3.215 (Korean)